Research Triangle Park, North Carolina, May 7, 2013 — Marken is experiencing significant growth in demand for their specialized handling and shipments of biopsied embryo cells to laboratories across the US. These cells are often used in Pre-Implantation Genetic Diagnostic Testing (PGD) and to diagnose certain diseases and conditions during in vitro fertilization (IVF) treatments. Marken is well known for its highly personalized service which requires that the samples are placed in customized, temperature controlled containers and rapidly transported to specialized laboratories, where they are tested, often within 24 hours. With time being such a critical element, the demand for Marken’s logistical services continues to grow with the increased demand for IVF and PGD services.
Marken is 100% dedicated to the life sciences industry, which makes them uniquely qualified to work with IVF clinics and PGD laboratories, universities and research centers that provide these services to patients.
Wes Wheeler, Marken’s Chief Executive Officer, believes more and more laboratories are turning to Marken for this type of specialized service. He commented, “We do whatever it takes to deliver these irreplaceable samples under any circumstances. The coordination and dedication between our local Marken staff and their laboratory customers is both impressive and heartwarming. The samples may arrive anytime during the day or night and our teams will stay until the last sample is delivered. We understand our role in delivering to the laboratories as quickly and as safely as possible. It’s a powerful mission.”
1IVF can be a complex and expensive procedure, increasing the critical nature of selecting a specialized courier who can guarantee on-time delivery and careful handling of their samples. An international committee estimates that the total number of IVF births has reached five million worldwide. With such a longstanding history in the pharma industry, Marken is poised to continue to lead and grow the challenging dynamics of supplying logistics to the market for Assisted Reproductive Technologies.